BiotechTube
Home/Avidicure/Arthur Lahr
AL

Arthur Lahr

CEO

Avidicure

Therapeutic Areas

OncologyAutoimmune Diseases

Avidicure Pipeline

DrugIndicationPhase
AVC-S-201AML and other blood cancers/solid tumorsPreclinical

Leadership Team at Avidicure

DD
Dirk De Naeyer
COO
RF
Robert Friesen
CSO
GS
Govert Schouten
CBO
View full Avidicure profile